Exploring the effects of S.mansoni infection treatment on female HIV susceptibility
Channel: Immunopaedia
Date: 02/10/2019

Sci-Talk presentation by Sergey Yegorov , PhD, University of Toronto (Collaborative Project between Keystone Symposium and Immunopaedia)

Sergey is a recent Immunology PhD graduate from the laboratory of Dr. Rupert Kaul at the University of Toronto. His PhD research focused on endemic East African infections and HIV susceptibility. The central component of his thesis is a Uganda-based translational clinical trial, which he describes in his Sci-Talk. "Specifically, this study explored whether and how treatment of S. mansoni could affect HIV susceptibility in Ugandan women and I hope that the novel results from this work will open up new avenues for HIV prevention in the East Africa region.""I am thankful to be part of the Immunopaedia-Keystone initiative and think that this is a great opportunity for young scholars to showcase their work to a broad audience around the globe."The results of this research have also been recently published in Nature Communications this year.